QA: Intra Cellular Therapies Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001567514_2022_Intra_Cellular_Therapies_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001567514, Intra Cellular Therapies Inc

  xvar xval
0 AssetsCurrent 467,280,830
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,790,724
3 remainder_Assets 20,850,542
4 LiabilitiesCurrent 53,356,478
5 LiabilitiesNoncurrent 18,674,943
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 621,171,507
9 ResearchAndDevelopmentExpense 84,500,962
10 remainder_Expenses 15,905,591
11 remainder_Revenues 388,628,389
12 remainder_NetIncome 2,468,039
13 remainder_ComprehensiveNetIncome -584,255
  yvar yval
0 Assets 489,922,096
1 Liabilities 72,031,421
2 Expenses 721,578,060
3 Revenues 388,628,389
4 StockholdersEquity 417,890,675
5 NetIncome -330,481,632
6 ComprehensiveNetIncome -330,773,760
7 BaseVar 837,606,130
8 EconomicCapitalRatiobeforeLimitedLiability 2.07
9 EconomicCapitalRatio 3.07

Edgar->Model Mapping

Feature Distribution

Change over Time